Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19

The SARS-CoV-2, the virus that causes COVID-19, has infected millions of people worldwide. The symptoms of this disease are primarily due to pulmonary involvement, uncontrolled tissue inflammation, and inadequate immune response against the invader virus. Impaired interferon (IFN) production is one...

Descripción completa

Detalles Bibliográficos
Autores principales: Babajani, Amirhesam, Hosseini-Monfared, Pooya, Abbaspour, Samin, Jamshidi, Elham, Niknejad, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226075/
https://www.ncbi.nlm.nih.gov/pubmed/34179022
http://dx.doi.org/10.3389/fcell.2021.695362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226075/
https://www.ncbi.nlm.nih.gov/pubmed/34179022
http://dx.doi.org/10.3389/fcell.2021.695362

Ejemplares similares